Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)
Italy
· Delayed Price · Currency is EUR 54.10
-0.75 (-1.37%)
Feb 21, 2025, 5:35 PM CET
Recordati Industria Chimica e Farmaceutica Employees
Recordati Industria Chimica e Farmaceutica had 4,450 employees as of December 31, 2024. The number of employees decreased by 5 or -0.11% compared to the previous year.
Employees
4,450
Change (1Y)
-5
Growth (1Y)
-0.11%
Revenue / Employee
€525,612
Profits / Employee
€93,490
Market Cap
11.06B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Amplifon | 12,715 |
| DiaSorin | 3,233 |
| EL.En. | 2,082 |
| Philogen | 165 |
| Pharmanutra | 105 |
| Garofalo Health Care | 2,767 |
| Safilo Group | 3,828 |
| GPI S.p.A. | 7,638 |
Recordati Industria Chimica e Farmaceutica News
- 8 days ago - There is still such a huge need to do better with rare diseases: Recordati CEO - CNBC
- 3 months ago - Angelini Pharma Said to Discuss Combination With CVC’s Recordati - BNN Bloomberg
- 3 months ago - Recordati CEO sees 'substantial opportunity' in Sanofi drug purchase - CNBC
- 3 months ago - Recordati SpA (RICFY) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - GuruFocus
- 3 months ago - Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Recordati reports nine-month results - Seeking Alpha
- 5 months ago - Sanofi Sells Global Rights To Rare Autoimmume Drug Enjaymo For $825M Upfront To Italian Firm Recordati - Benzinga
- 5 months ago - Recordati buys rights to rare immune disorder drug from Sanofi for $825mln - Zawya